Financhill
Sell
19

CRSP Quote, Financials, Valuation and Earnings

Last price:
$42.81
Seasonality move :
6.36%
Day range:
$41.94 - $43.48
52-week range:
$36.52 - $75.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.87x
Volume:
1.4M
Avg. volume:
2.4M
1-year change:
-41.51%
Market cap:
$3.6B
Revenue:
$35M
EPS (TTM):
-$4.37

CRSP Analysts' Consensus Rating

The 24 analysts providing 12-month price projections for CRISPR Therapeutics AG shares anticipate an average target of $83.60, ranging from a low estimate of $32.00 to a high estimate of $268.00. This average target implies a growth of 98.48% compared to the current stock price of $42.12.

Consensus Price Target

$83.60

Highest Price Target

$268.00

Lowest Price Target

$32.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 10 11 12

Hold 11 11 11

Sell 2 2 1
Consensus Hold Leans Bullish Buy

CRSP Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Is Ford Stock Undervalued Amid the EV Transition?
Is Ford Stock Undervalued Amid the EV Transition?

There is a lot going on in the electric vehicle…

Is Goldman Sachs Stock a Buy Sell or Hold?
Is Goldman Sachs Stock a Buy Sell or Hold?

When the Federal Reserve started hiking rates in 2022, banks’…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Sell
49
SMTC alert for Mar 17

Semtech [SMTC] is down 0.49% over the past day.

Buy
62
PLPC alert for Mar 17

Preformed Line Products [PLPC] is up 3.8% over the past day.

Sell
50
NUTX alert for Mar 17

Nutex Health [NUTX] is up 4.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock